1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Global Formulation Development Outsourcing Market
4. Voice of Customer
5. Executive Summary
6. Global Formulation
Development Outsourcing Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Services
(Pre-Formulation Services v/s Formulation Optimization)
6.2.1.1.
By Pre-Formulation Services (Discovery & Preclinical
Services v/s Analytical Services)
6.2.1.2.
By Formulation Optimization (Phase I, Phase II, Phase
III, Phase IV)
6.2.2. By Dosage Form
(Oral, Topical, Intravenous, Others)
6.2.3. By Application (Oncology,
Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular,
Others)
6.2.4. By End User (Pharmaceutical
& Biopharmaceutical Companies, Governments, Academic & Research Institutions,
Others)
6.2.5. By Region
6.2.6. By Company (2021)
6.3.
Product Market Map
7. North America Formulation
Development Outsourcing Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Services
(Pre-Formulation Services v/s Formulation Optimization)
7.2.1.1.
By Pre-Formulation Services (Discovery & Preclinical Services
v/s Analytical Services)
7.2.1.2.
By Formulation Optimization (Phase I, Phase II, Phase
III, Phase IV)
7.2.2. By Dosage Form
(Oral, Topical, Intravenous, Others)
7.2.3. By Application (Oncology,
Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular,
Others)
7.2.4. By End User (Pharmaceutical
& Biopharmaceutical Companies, Governments, Academic & Research Institutions,
Others)
7.2.5. By Country
7.3.
North America: Country Analysis
7.3.1. United States Formulation
Development Outsourcing Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Services
7.3.1.2.2.
By Dosage Form
7.3.1.2.3.
By Application
7.3.1.2.4.
By End User
7.3.2. Mexico Formulation
Development Outsourcing Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Services
7.3.2.2.2.
By Dosage Form
7.3.2.2.3.
By Application
7.3.2.2.4.
By End User
7.3.3. Canada Formulation
Development Outsourcing Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Services
7.3.3.2.2.
By Dosage Form
7.3.3.2.3.
By Application
7.3.3.2.4.
By End User
8. Europe Formulation
Development Outsourcing Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Services
(Pre-Formulation Services v/s Formulation Optimization)
8.2.1.1.
By Pre-Formulation Services (Discovery & Preclinical
Services v/s Analytical Services)
8.2.1.2.
By Formulation Optimization (Phase I, Phase II, Phase
III, Phase IV)
8.2.2. By Dosage Form
(Oral, Topical, Intravenous, Others)
8.2.3. By Application (Oncology,
Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular,
Others)
8.2.4. By End User (Pharmaceutical
& Biopharmaceutical Companies, Governments, Academic & Research Institutions,
Others)
8.2.5. By Country
8.3.
Europe: Country Analysis
8.3.1. France Formulation
Development Outsourcing Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Services
8.3.1.2.2.
By Dosage Form
8.3.1.2.3.
By Application
8.3.1.2.4.
By End User
8.3.2. United Kingdom Formulation
Development Outsourcing Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Services
8.3.2.2.2.
By Dosage Form
8.3.2.2.3.
By Application
8.3.2.2.4.
By End User
8.3.3. Italy Formulation
Development Outsourcing Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Services
8.3.3.2.2.
By Dosage Form
8.3.3.2.3.
By Application
8.3.3.2.4.
By End User
8.3.4. Germany Formulation
Development Outsourcing Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Services
8.3.4.2.2.
By Dosage Form
8.3.4.2.3.
By Application
8.3.4.2.4.
By End User
8.3.5. Spain Formulation
Development Outsourcing Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Services
8.3.5.2.2.
By Dosage Form
8.3.5.2.3.
By Application
8.3.5.2.4.
By End User
9. Asia-Pacific Formulation
Development Outsourcing Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Services
(Pre-Formulation Services v/s Formulation Optimization)
9.2.1.1.
By Pre-Formulation Services (Discovery & Preclinical
Services v/s Analytical Services)
9.2.1.2.
By Formulation Optimization (Phase I, Phase II, Phase
III, Phase IV)
9.2.2. By Dosage Form
(Oral, Topical, Intravenous, Others)
9.2.3. By Application (Oncology,
Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular,
Others)
9.2.4. By End User (Pharmaceutical
& Biopharmaceutical Companies, Governments, Academic & Research Institutions,
Others)
9.2.5. By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1. China Formulation
Development Outsourcing Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Services
9.3.1.2.2.
By Dosage Form
9.3.1.2.3.
By Application
9.3.1.2.4.
By End User
9.3.2. India Formulation
Development Outsourcing Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Services
9.3.2.2.2.
By Dosage Form
9.3.2.2.3.
By Application
9.3.2.2.4.
By End User
9.3.3. Japan Formulation
Development Outsourcing Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Services
9.3.3.2.2.
By Dosage Form
9.3.3.2.3.
By Application
9.3.3.2.4.
By End User
9.3.4. South Korea
Formulation Development Outsourcing Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Services
9.3.4.2.2.
By Dosage Form
9.3.4.2.3.
By Application
9.3.4.2.4.
By End User
9.3.5. Australia Formulation
Development Outsourcing Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Services
9.3.5.2.2.
By Dosage Form
9.3.5.2.3.
By Application
9.3.5.2.4.
By End User
10. South America Formulation
Development Outsourcing Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Services
(Pre-Formulation Services v/s Formulation Optimization)
10.2.1.1. By Pre-Formulation
Services (Discovery & Preclinical Services v/s Analytical Services)
10.2.1.2. By Formulation
Optimization (Phase I, Phase II, Phase III, Phase IV)
10.2.2. By Dosage Form
(Oral, Topical, Intravenous, Others)
10.2.3. By Application (Oncology,
Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular,
Others)
10.2.4. By End User (Pharmaceutical
& Biopharmaceutical Companies, Governments, Academic & Research Institutions,
Others)
10.2.5. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Formulation
Development Outsourcing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Services
10.3.1.2.2.
By Dosage Form
10.3.1.2.3.
By Application
10.3.1.2.4.
By End User
10.3.2. Argentina Formulation
Development Outsourcing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Services
10.3.2.2.2.
By Dosage Form
10.3.2.2.3.
By Application
10.3.2.2.4.
By End User
10.3.3. Colombia Formulation
Development Outsourcing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Services
10.3.3.2.2.
By Dosage Form
10.3.3.2.3.
By Application
10.3.3.2.4.
By End User
11. Middle East and
Africa Formulation Development Outsourcing Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Services (Pre-Formulation
Services v/s Formulation Optimization)
11.2.1.1. By Pre-Formulation
Services (Discovery & Preclinical Services v/s Analytical Services)
11.2.1.2. By Formulation
Optimization (Phase I, Phase II, Phase III, Phase IV)
11.2.2. By Dosage Form
(Oral, Topical, Intravenous, Others)
11.2.3. By Application (Oncology,
Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular,
Others)
11.2.4. By End User (Pharmaceutical
& Biopharmaceutical Companies, Governments, Academic & Research Institutions,
Others)
11.2.5. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa Formulation
Development Outsourcing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Services
11.3.1.2.2.
By Dosage Form
11.3.1.2.3.
By Application
11.3.1.2.4.
By End User
11.3.2. UAE Formulation
Development Outsourcing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Services
11.3.2.2.2.
By Dosage Form
11.3.2.2.3.
By Application
11.3.2.2.4.
By End User
11.3.3. Saudi Arabia Formulation
Development Outsourcing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Services
11.3.3.2.2.
By Dosage Form
11.3.3.2.3.
By Application
11.3.3.2.4.
By End User
11.3.4. Kuwait Formulation
Development Outsourcing Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1.
By Services
11.3.4.2.2.
By Dosage Form
11.3.4.2.3.
By Application
11.3.4.2.4.
By End User
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Competitive
Landscape (Inclusive of SWOT Analysis)
14.1.
Charles River Laboratories International, Inc.
14.2.
Catalent Inc.
14.3.
Quotient Bioresearch Ltd.
14.4.
Aizant Drug Research Solutions Private Limited
14.5.
Laboratory Corporation of America Holdings
14.6.
Syngene International Ltd
14.7.
Irisys LLC
14.8.
Intertek Group plc
14.9.
Piramal Pharma Limited
14.10.
Emergent BioSolutions Inc.
14.11.
Lonza Group AG
14.12.
Dr. Reddy's Laboratories Ltd
14.13.
Thermo Fischer Scientific, Inc. (Patheon)
14.14.
PCI Pharma Services
14.15.
Hermes Pharma
15. Strategic Recommendations
In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com